RBC Life Sciences, Inc. (RBCL)

RBC Life Sciences Revenue

RBC Life Sciences had revenue of $5.41M in the quarter ending September 30, 2015, a decrease of -28.06%. This brings the company's total for the last twelve months to $24.12M, down -12.49% year-over-year. In the year 2014, RBC Life Sciences had annual revenue of $28.27M with 10.99% growth. That makes RBC Life Sciences the 32,677th largest company in the world by revenue and 4,301st in the United States.

• Revenue (ttm): 24.12M
• Revenue Growth: -12.49%
• P/S Ratio: 0.00
• Revenue / Employee: 270.96K
• Employees: 89
• Market Cap: 29.55K

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Nutritional Products 22.07M 78.1%
• Medical Products 6.20M 21.9%

By Geography

Chart

• Russia/Eastern Europe 10.63M 37.6%
• United States 8.97M 31.7%
• Southeast Asia 7.25M 25.6%
• Canada 1.22M 4.3%
• All Others 195.00K 0.7%

Fiscal year ended Dec 31, 2014

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2014	28.27M	2.80M	10.99%
Dec 31, 2013	25.47M	310.76K	1.24%
Dec 31, 2012	25.16M	-3.29M	-11.56%
Dec 31, 2011	28.45M	290.96K	1.03%
Dec 31, 2010	28.16M	3.23M	12.97%

Data Source: S&P Global Market Intelligence Last updated: Nov 16, 2015

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error